Evidence map›Paper›PMID 26526153›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2017

Boron nitride nanotubes and nanoplatelets as reinforcing agents of polymeric matrices for bone tissue engineering.

Behzad Farshid, Gaurav Lalwani, Meisam Shir Mohammadi, John Simonsen, Balaji Sitharaman

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Nanostructured Biomaterials for Bone Regeneration.Frontiers in bioengineering and biotechnology · 2020
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Toxicology of graphene-based nanomaterials.Advanced drug delivery reviews · 2016
    Review
  12. Article
  13. Principles of Biocompatible Nanotube Design for High-Performance Biomaterials.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Behzad FarshidDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, New York, 11794.
Gaurav LalwaniDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, New York, 11794.ORCID 0000-0001-7769-7481
Meisam Shir MohammadiDepartment of Wood Science and Engineering, Oregon State University, Corvallis, Oregon, 97331.
John SimonsenDepartment of Wood Science and Engineering, Oregon State University, Corvallis, Oregon, 97331.
Balaji SitharamanDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, New York, 11794.ORCID 0000-0001-8391-8076

Funding

Nanotechnology-based Theranostic Technology for Bone Tissue EngineeringDP2OD007394 · OD · STATE UNIVERSITY NEW YORK STONY BROOK · PI SITHARAMAN, BALAJI · 2010 to 2010
$2.4M
NIH HHS DP2 OD007394
6 · The paper itself

Abstract

This study investigates the mechanical properties and in vitro cytotoxicity of one- and two-dimensional boron nitride nanomaterials-reinforced biodegradable polymeric nanocomposites. Poly(propylene fumarate) (PPF) nanocomposites were fabricated using crosslinking agent N-vinyl pyrrolidone and inorganic nanomaterials: boron nitride nanotubes (BNNTs) and boron nitride nanoplatelets (BNNPs) dispersed at 0.2 wt % in the polymeric matrix. The incorporation of BNNPs and BNNTs resulted in a ∼38 and ∼15% increase in compressive (Young's) modulus, and ∼31 and ∼6% increase in compressive yield strength compared to PPF control, respectively. The nanocomposites showed a time-dependent increased protein adsorption for collagen I protein. The cytotoxicity evaluation of aqueous BNNT and BNNP dispersions (at 1-100 μg/mL concentrations) using murine MC3T3 preosteoblast cells showed ∼73-99% viability. The cytotoxicity evaluation of media extracts of nanocomposites before crosslinking, after crosslinking, and upon degradation (using 1×-100× dilutions) showed dose-dependent cytotoxicity responses. Crosslinked nanocomposites showed excellent (∼79-100%) cell viability, cellular attachment (∼57-67%), and spreading similar to cells grown on the surface of tissue culture polystyrene control. The media extracts of degradation products showed a dose-dependent cytotoxicity. The favorable cytocompatibility results in combination with improved mechanical properties of BNNT and BNNP nanocomposites opens new avenues for further in vitro and in vivo safety and efficacy studies towards bone tissue engineering applications. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 406-419, 2017.

Indexed as

Materials TestingTissue EngineeringBone SubstitutesBoron CompoundsCell LineFumaratesNanocompositesNanotubesOsteoblastsPolypropylenesBone SubstitutesBoron Compoundsboron nitrideFumaratespoly(propylene fumarate)Polypropylenesbiodegradable polymerbone tissue engineeringboron nitridecytotoxicityinorganic nanomaterialsmechanical properties

Identifiers

PMID26526153
PMCPMC4854812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.